| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.2M | +9.3% |
| SG&A Expense | $9.6M | +46.6% |
| Operating Income | -$28.8M | -19.4% |
| Pre-tax Income | -$28.7M | -18.8% |
| Income Tax | -$60K | — |
| Net Income | -$28.6M | -18.6% |
| EPS (Basic) | -$4.05 | -841.9% |
| EPS (Diluted) | -$4.05 | -432.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.9M | -44.4% |
| Current Assets | $20.5M | -43.9% |
| Total Assets | $21.6M | -42.0% |
| Current Liabilities | $5.5M | +38.6% |
| Total Liabilities | $6.1M | +46.3% |
| Stockholders' Equity | $15.5M | -53.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.2M | -11.8% |
| Capital Expenditures | $226K | +59.9% |
| Investing Cash Flow | -$226K | -59.9% |
| Financing Cash Flow | $9.6M | +669.6% |
| Free Cash Flow | -$25.4M | -12.1% |